Mark E. Delaney - 29 Jan 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting relationship: SVP & Chief Commercial Officer
Issuer ticker: DGX
Reported as of: 29 Jan 2025
Net transaction value: +$632
SEC form: 4
Accepted by SEC: 31 Jan 2025, 16:28:55 UTC
Prior SEC filing: 25 Oct 2024
Next SEC filing: 07 Feb 2025
Source filing: View source filing
Reporting owner signature: Sean D. Mersten, Attorney in Fact for Mark E. Delaney

Key filing fact

Mark E. Delaney filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 31 Jan 2025.

Key facts

This page summarizes Mark E. Delaney's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Jan 2025, 16:28.

Change

Previous filing in this sequence was filed on 25 Oct 2024.
Current net transaction value: +$632.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Small acquisition under Rule 16a-6

Transaction value: $632
Shares: +4
Change %: +0.08%
Price: $158.02
Shares after: 5,027
Date: 29 Jan 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.